Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Randomised Phase II Screening Study to be Used in an TP/TPF-chemotherapy (Short Induction) Before TP/TPF-induction, Radiotherapy With or Without Cetuximab in the Primary Therapy of the Only by Laryngectomy Operable Carcinoma of the Larynx/Hypopharynx

NCT00508664 is registered in ClinicalTrials.gov with ClinAssess as lead sponsor.

NCT NCT00508664
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00508664 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Randomised Phase II Screening Study to be Used in an TP/TPF-chemotherapy (Short Induction) Before TP/TPF-induction, Radiotherapy With or Without Cetuximab in the Primary Therapy of the Only by Laryngectomy Operable Carcinoma of the Larynx/Hypopharynx
Lead sponsor
ClinAssess
Phase
Phase 2
Overall status
Completed
Start date
July 31, 2007
Completion date
February 28, 2015
Enrollment
180 (actual)
Sites
27

Conditions

As the registry lists them; a condition with its own page is linked.

larynx carcinoma, squamous cell carcinoma of the hypopharynx